Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.280
-0.070 (-1.61%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
134
Market Cap
159.72M USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.97M | -2.07M | -29.38% |
| Dec 31, 2023 | 7.04M | -182.56M | -96.29% |
| Dec 31, 2022 | 189.60M | 179.85M | 1,843.82% |
| Dec 31, 2021 | 9.75M | 410.00K | 4.39% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 114.20M |
| Spero Therapeutics | 66.80M |
| ProQR Therapeutics | 19.19M |
| Fate Therapeutics | 6.65M |
| Alps Group | 3.74M |
| Oramed Pharmaceuticals | 2.00M |
| Spruce Biosciences | 697.00K |
MOLN News
- 9 days ago - Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712 - GlobeNewsWire
- 14 days ago - Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting - GlobeNewsWire
- 5 weeks ago - Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes - GlobeNewsWire
- 6 weeks ago - Molecular Partners to Hold Three Poster Presentations at AACR 2026 - GlobeNewsWire
- 6 weeks ago - Molecular Partners Reports Highlights and Financial Results for Full Year 2025 - GlobeNewsWire
- 2 months ago - Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results - GlobeNewsWire
- 3 months ago - Molecular Partners AG Transcript: Study update - Transcripts